Role of RAS Mutation Status as a Prognostic Factor for Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy Based on Fluoropyrimidines and Oxaliplatin, With or Without Bevavizumab: A Retrospective Analysis

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2017.1149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2011English

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

Oncology Letters
Cancer ResearchOncology
2011English

Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2014English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Combination Therapy With Docetaxel and S-1 as a First-Line Treatment in Patients With Advanced or Recurrent Gastric Cancer: A Retrospective Analysis

World Journal of Surgical Oncology
SurgeryOncology
2010English

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Oncotarget
Oncology
2017English

Clinical Efficacy and Safety of Nimotuzumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer: A Retrospective Analysis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

Significance of Serum Ferritin as a Prognostic Factor in Advanced Hepatobiliary Cancer Patients Treated With Korean Medicine: A Retrospective Cohort Study

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2018English

First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy